JUN and urinary bladder carcinoma: In this study, we elucidated JNKs/c-Jun activation with the degradation of phosphatase PH domain and Leucine rich repeat Protein Phosphatases (PHLPP2), as well as apoptotic induction and anti-cancer effects in Chel A-treated human bladder cancer cells.